But Putin, who is famed for his talent for headline-grabbing announcements, did not give any name for the vaccine, nor did he say how it worked, who was developing it or give details of any trials.
"We have good news," Putin was quoted as saying by RIA Novosti news agency.
Also Read
To date no approved vaccine or treatment for Ebola exists and the UN's World Health Organization has authorised the fast-track development of drugs.
The pharmaceutical scramble sparked by the two-year Ebola crisis -- which killed more than 11,000 people in west Africa -- has yielded several promising vaccine candidates but none has yet been tested in general, non-infected populations -- the gold standard for proving efficacy.
Similarly, none of the many potential treatments under investigation has been shown to work.
Health Minister Veronika Skvortsova said at a government meeting with Putin that Russia has developed a vaccine that was "unique and has no equivalents in the world".
In October 2014, Skvortsova said Russia expected to produce three Ebola vaccines within the following six months, and that one was ready for a clinical trial.
The Ebola epidemic is due to be declared over on tomorrow with Liberia expecting the all-clear.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)